Skip to main content
. Author manuscript; available in PMC: 2018 Jun 1.
Published in final edited form as: J Cancer Surviv. 2017 Jan 13;11(3):393–400. doi: 10.1007/s11764-017-0596-1

Table 1.

Non- inferiority test results comparing survey response rates across study arm

Comparison Arm 1 response rate Comparator response rate Unadjusted Estimate 95% Confidence Interval Adjusted Estimatea 95% Confidence Interval
Arm 2 – Arm 1b 59.9% 51.2% −8.7% −13.1, −4.4% −8.5% −12.7, −4.2%
Arm 3 – Arm 1 59.9% 51.9% −8.0% −12.4, −3.7% −8.7% −13.0, −4.4%
Arm 4 – Arm 1 59.9% 37.9% −22.0% −26.3, −17.7% −23.2% −27.5, −19.0%
a

Adjusted for gender, race/ethnicity, age at diagnosis, year of diagnosis

b

Arm 1 is the gold standard.

For all comparisons, the lower equivalence margin (−5%) is within or above the 95% confidence interval; thus there is not enough evidence to reject the null hypothesis of inferiority.